ROMA (Risk of Ovarian Malignancy Algorithm)

ROMA (Risk of Ovarian Malignancy Algorithm) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.

Open the ROMA (Risk of Ovarian Malignancy Algorithm) → Runs in your browser. No signup, no tracking.

What this is

ROMA (Risk of Ovarian Malignancy Algorithm) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. ROMA (Risk of Ovarian Malignancy Algorithm) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.

When to use it

Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.

References

Moore RG, McMeekin DS, Brown AK, et al. A novel multiple marker bioassay utilizing HE4 and CA125 to predict epithelial ovarian cancer in patients with a pelvic mass. Gynecol Oncol. 2009;112(1):40-46. Read the source ↗

Worked example: ROMA 62.1% (postmenopausal; high-risk cut-point 27.7%): elevated risk of epithelial ovarian cancer.

Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.

Built by Clay Good. Source on GitHub.